A remarkable milestone has been achieved by the Armed Forces Bone Marrow Tran (AFBMTC), Rawalpindi, with the sucGFRAH 2 Pakistan's first-ever CAR T-cell theraJ

The groundbreaking treatment was old patient battling relapsed and trea Acute Lymphoblastic Leukaemia (B- relapsed twice despite previous ther received indigenously developed ant therapy on 18 June 2026. By Day +1 MRD-negative complete remission a discharged on 3 July 2026.

This achievement represents far more than a single successful procedure it marks the beginning of a new era in Pakistan's healthcare system. For the first time, patients in the country now have access to one of the world's most advanced cellular immunotherapies, offering renewed hope to those who have exhausted conventional treatment options.

This historic success reflects years of unwavering commitment, research, and teamwork by the dedicated physicians, scientists, laboratory specialists, apheresis and cell processing experts, and nursing staff of the Army Medical Corps. Their tireless efforts have brought Pakistan to the forefront of advanced cancer treatment.

Special appreciation goes to the patient and their family for placing their trust in this pioneering therapy and demonstrating extraordinary courage throughout the journey.

May this be the first of many lives transformed through this revolutionary treatment. Insha'Allah, many more patients will benefit from this breakthrough in the years ahead.